Dr. Matthew Miller is the Director of the Degroote Institute of Infection Disease Research and a Canada Research Chair in Viral Pandemics. His research interests include pandemics, influenza virus, virus/host interactions, vaccines and more. Over the COVID-19 pandemic, he was one of the co-principal investigators behind McMaster’s inhaled COVID-19 vaccines. Miller believes the innovative approach of expressing three different SARS-CoV-2 proteins rather than only the distinctive spike protein has the potential to make a large impact on public health.

Contributors:
Video editor: Brooke D’Mello
Interviewer: Brooke D’Mello and Ken Yu
Interviewee: Dr. Matthew Miller

Check out more from The Meducator:
[ Ссылка ]
[ Ссылка ]
[ Ссылка ]-
1gAqIim9Eug3ItlG_sfgQJVOz7L2f9cy07u9Kd2Nq3U0wGx3Dn7YNKm0AE&_rdr

свернуть